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We report three cases of symptomatic acute carotid thrombosis occurring after carotid artery stenting (CAS).
Case 1: A patient presented with crescendo transient ischemic attacks on the second day after CAS. Ultrasound images
demonstrated incomplete in-stent thrombosis due to plaque protrusion. The urgent surgical procedure consisted of stent
removal and carotid thromboendarterectomy.
Case 2: A case of complete thrombosis of a carotid stent occurred 4 days after implantation in a patient with essential
thrombocythemia diagnosed by chance. The surgical strategy included stent removal and carotid thromboendarterec-
tomy.
Case 3: Cardiac multiple embolisms in a patient with chronic atrial fibrillation caused concomitant leg ischemia and acute
carotid stent occlusion 2 hours after CAS. Cerebral reperfusion was established by embolectomy, without removing the
stent. At the same time, the right leg ischemia was resolved by a thromboembolectomy with a Fogarty catheter.
These three cases demonstrate that acute thrombosis after carotid stenting can be managed successfully with emergent
surgical intervention. Thromboendarterectomy with stent removal or in selected cases, simple thromboembolectomy, can
minimize neurologic sequelae in patients suffering from acute post-stenting carotid thrombosis. ( J Vasc Surg 2005;42:
993-6.)The use of carotid artery angioplasty and stenting
(CAS) is progressively increasing in the treatment of ex-
tracranial carotid artery stenosis.1-3 As described in other
reports, acute occlusion of the treated segment can repre-
sent an early complication of the endovascular approach.4,5
Carotid artery thrombosis is a rare but potentially devastat-
ing complication of CAS.6
CASE REPORTS
In our series of 562 CAS performed between December 2000
and March 2005, we observed three cases of acute carotid throm-
bosis after the procedure.
Pre- and postcarotid angioplasty and stenting protocol. A
neurologist examines patients before each procedure to ascertain
neurologic function. Brain scans by either computed tomography
(CT) or magnetic resonance imaging (MRI) are also performed in
all cases.
Patients treated electively receive clopidogrel (75 mg/d) plus
aspirin (325 mg/d) or ticlopidine (500 mg/d) plus aspirin (100
mg/d) for at least 3 days before the operation. Patients who do not
undergo premedication and are not taking any long-term anti-
platelet therapy receive a 300-mg loading dose of clopidogrel
before the operation. Patients receiving coumarin anticoagulant
therapy are converted to an intravenous (IV) infusion of heparin
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doi:10.1016/j.jvs.2005.06.031(25,000 IU/24 h) associated with aspirin (100 mg/d) at least 5
days before the operation. During CAS procedure, weight-
adjusted (70 U/kg) heparin is administered and repeated as nec-
essary to maintain an activated clotting time of 225 to 250 seconds
throughout the intervention.
Within 24 hours after CAS, a carotid duplex scan is done and
the same protocol neurologist examines each patient. In the ab-
sence of any neurologic change, the patient is discharged on the
first or second day.
The duplex antiplatelet regimen is continued after stent implan-
tation, but the ticlopidine or clopidogrel component is discontinued
after 2 months. Patients with previous anticoagulant therapy are
reconverted to coumarin, which is continued in combination with
aspirin until 30 days post-CAS.
Case 1. An 82-year-oldman with severe ischemic cardiopathy
reported two episodes of transient right-sided hemiplegia. An
ultrasound scan demonstrated severe left carotid artery stenosis
(plaque substantially hypoechoic with small areas of hyperechoic-
ity, type 2 Gray-Weale classification7). He underwent endovascular
treatment using a cerebral protection device (Epi-filter, Boston
Scientific, Natick, Mass), and carotid artery stent placement (Ca-
rotid Wallstent, Boston Scientific).
In the immediate postoperative period the patient was asymp-
tomatic, but 2 days later, he suffered a series of crescendo transient
ischemic attacks. A duplex ultrasound scan demonstrated incom-
plete in-stent thrombosis (Fig 1), and urgent surgical removal of
the stent was planned. During the procedure, we noted a plaque
prolapse through the cell stent, with an overlying thrombus. The
stent was removed and carotid thromboendarterectomy was per-
formed with patch closure after shunt placement. Full neurologic
recovery occurred in the first postoperative day.
Case 2. A 78-year-old man presented with transient ocular
blindness in the left eye. A duplex ultrasound scan demonstrated
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to a predominantly echogenic plaque with small areas of hypo-
echoicity (type 3, Gray-Weale classification7) and total occlusion of
the right carotid artery. He successfully underwent CAS (Carotid
Wallstent with Epi-filter, Boston Scientific) andwas discharged 2 days
after the operation with dual antiaggregation therapy (acetylsalicylic
acid, 100 mg/d; ticlopidine, 500 mg/d).
Four days later he returned with a severe neurologic deficit and
decreased level of consciousness, which had begun 4 hours earlier.
His family informed us that he had stopped taking the antiaggre-
gation therapy 2 days before because of a terrible stomach ache.
The duplex ultrasound scan showed complete stent thrombosis in
the left internal carotid artery (Fig 2). We decided to perform
urgent surgical neck exploration. Under general anesthesia, we
removed the stent and performed an endarterectomy with shunt-
ing and patching (Fig 3).
At the time of readmission to the hospital, the patient’s
platelet counts had increased to 810,000 mm3 and the leukocyte
count was 33,000 mm3. The hematologic diagnosis was consistent
with essential thrombocythemia with consequent leukocytosis.
The patient made a gradual improvement from the stroke and was
discharged on the eighth day after the operation with dual antiag-
gregation therapy.
Case 3. The patient was a 72–year-old man with hyperten-
sion, cardiopathy (previous coronary artery bypass graft), and
chronic atrial fibrillation, who presented with hemodynamic right
Fig 1. Ultrasound images demonstrate incomplete sten
(a) transversal scan; (b) longitudinal scan.
Fig 2. Complete carotid stent occlusion in a patient with
thrombocythemia.carotid artery stenosis due to a predominantly echogenic plaquewith small areas of hypoechoicity (type 3, Gray-Weale classifica-
tion7).
Five days before the CAS procedure, we converted his antico-
agulation therapy from Coumadin (Bristol-Myers Squibb, New
York, NY) to heparin (IV infusion of 25,000 IU/24 h, obtaining
an activated partial thromboplastin time of 70 seconds on the day
of the operation) plus aspirin (100 mg/d). During the procedure,
an additional IV bolus of heparin (5000 IU) was administered.
Two hours after CAS (Carotid Wallstent with Epi-filter, Bos-
ton Scientific), the patient had an acute stroke, with complete left
hemiplegia, associated with acute ischemia of the right leg. A
duplex ultrasound scan revealed complete carotid stent thrombosis
and right femoropopliteal occlusion. At the same time, the elec-
mbosis due to plaque protrusion through the cell stent:
Fig 3. Carotid stent removed.t throtrocardiogram showed significant arrhythmia as a result of atrial
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of the right atrium, with parietal thrombosis. Angiography con-
firmed that the carotid thrombosis was limited to the intrastent
segment (Fig 4).
We hypothesized a cardiac multiple embolism as the cause of
the two ischemic complications. The carotid bifurcation was dis-
sected through a right cervicotomy, under general anesthesia.
After clamping, we completed a transverse arteriotomy on the
common carotid near the stent and achieved successful thrombec-
tomy by careful aspiration. The entire clot was pulled out by using
forceps and an aspirator, and an excellent runoff was achieved
without the need to remove the stent (Fig 5). The arteriotomy was
closed by two semi-continuous running sutures, and cerebral
reperfusion was established. At the same time we resolved the right
leg ischemia by a thromboembolectomy with a Fogarty catheter.
The left hemiplegia vanished immediately, and the right tibial
pulses were appreciable. Two hours later, the patient presented an
acute ischemia of the left upper limb, which was resolved with a
thromboembolectomy using a Fogarty catheter.
Reconversion to Coumadin (Bristol-Myer Squibb) therapy be-
gan 2 days later, and aspirin was continued for 1 month. At 1-year
follow-up, the carotid stent has good patency and is correctly
Fig 4. An agiogram shows the carotid thrombosis limited to the
intrastent segment (cardiac embolism).located.DISCUSSION
The first experiences of carotid balloon angioplasty
reported in literature involved high risks of possible em-
bolic complications, suboptimal angiographic results, acute
vessel occlusion, elastic recoil, and restenosis. In recent
years, however, the introduction of adjunctive stenting has
partially mitigated many of these concerns.8,9 Several stud-
ies report an encouragingly low incidence of late complica-
tions after CAS, but there are little data regarding early
thrombotic complications after CAS.10-12
Acute carotid closure can be manifested by devastating
neurologic changes in the postoperative period. The man-
agement of poststent acute carotid thrombosis, as learned
from acute thrombosis after carotid endarterectomy, in-
cludes prompt surgical reintervention.13,14
Our three cases demonstrate the multifactorial patho-
genesis of acute carotid stent thrombosis and the impor-
tance of an accurate surgical strategy for each case (stent
removal in two patients, embolectomy in the other). In the
first case, we observed a plaque prolapse into the stent with
an overlying clot. Despite partial carotid thrombosis, we
preferred to remove the stent and perform a complete
endarterectomy. Case 2 was a patient with essential throm-
bocythemia, which is a hypercoagulable state that may
generally cause microvascular complications.15,16 The ca-
rotid stent thrombosis in this patient demonstrates that
occlusion of large arteries may also occur in patients with
thrombocytosis if another contributory factor, such as the
carotid stent material (stainless steel), is present. For this
reason, we decided that stent removal was the only defini-
tive solution. In the third case, stent occlusion was the
result of a multiembolic cardiac event, and surgical embo-
lectomy was successfully performed by careful aspiration of
the clot, without removing the stent. We preferred not to
use a Fogarty catheter to avoid the risk of stent dislocation.
Our experience strengthens the importance of a correct
Fig 5. Surgical strategy: (a) common carotid artery (CCA) and
external carotid artery (ECA) clamping, transverse arteriotomy of
the CCA (near the stent); (b) internal carotid artery (ICA) flow
reversal and embolectomy.pre-CAS and post-CAS antithrombotic treatment. Dual
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after any endovascular procedure, this being the time nec-
essary for completion of the re-endothelialization process
inside the stent.
In our practice, when we detect a neurologic deficit in
the early post-CAS period, we perform a prompt carotid
duplex examination (first level study). If the diagnosis is
either a partial or complete carotid intrastent thrombosis,
we immediately turn to surgical exploration. When a du-
plex examination result is negative or there is doubt about
the distal extension of carotid thrombosis, we perform a
second level study consisting of angiography (full cervical
and intracranial angiography with at least three vessel stud-
ies) or an angio-CT scan. With a diagnosis of intracranial
vessel occlusion, we choose a prompt endovascular ap-
proach with intraluminal thrombolysis.
In contrast, we have some concerns about treating an
extracranial vessel occlusion with an endoluminal approach.
Some authors report successful treatment of acute carotid
stent thrombosis by combination therapy using percutane-
ous mechanical thrombectomy and adjunctive intravenous
abciximab.17,18 Despite a number of cases with good re-
sults described in the literature, the endovascular approach
for acute carotid thrombosis presents some concerns about
the possibility of thrombus embolization during treatment.
The intraluminal manipulation of guides and catheters in
association with thrombolysis can cause the fragmentation
of clots and subsequently increase the risk of distal intrace-
rebral vessel occlusion.
Parodi et al19 recently described a case of endovascular
treatment of a symptomatic free-floating thrombus of the
internal carotid artery using flow reversal. Suction embo-
lectomy with an antiembolism system involves less risk of
distal embolization in the case of partial internal carotid
thrombosis, but concerns remain for cases with total occlu-
sion of the carotid axis in which the clot can extend to
include the common and external carotid artery. In these
cases, we believe that all endovascular attempts should be
avoided and that immediate surgical neck exploration is the
only alternative.
We have previously described the management of late
complications of carotid stenting,20 the most frequent of
which is in-stent restenosis. This complication can be suc-
cessfully managed by a further endovascular approach (re-
peat conventional angioplasty, repeat stenting, cutting bal-
loon angioplasty) and seldom requires surgical conversion.
On the contrary, the management of acute poststent
carotid thrombosis is very similar to the management of
acute postendarterectomy carotid thrombosis. Both re-
quire emergent evaluation and emergent definitive surgical
repair to minimize neurologic morbidity.REFERENCES
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